Packaging can help create competitive advantage and product differentiation in industries where tangible differences are difficult. Bilcare provides innovative packaging solutions to help pharmaceutical brands address challenges like compliance, communication, convenience, and counterfeiting. Their solutions include child-resistant and compliance-enhancing packaging, as well as designs that build brand associations and identities. Bilcare's innovative approaches help improve medication adherence and safety while strengthening brands.
For those of you that are looking to manufacture their own line of vitamin and supplement products, I definitely recommend checking out our article from December 2009 entitled "Packaging and Labeling Trends for 2010." This will help you understand what packaging designs are most suitable for your products and some things to consider when designing your product labels.
GetPersonalized! Pharma's perspective on the future, Claudia KarnbachSitra / Hyvinvointi
Pharma's perspective on the future, Claudia Karnbach, Head, Global Business Development and Licensing, Specialty Medicine, Bayer Healthcare Pharmaceuticals (USA, New York)
For those of you that are looking to manufacture their own line of vitamin and supplement products, I definitely recommend checking out our article from December 2009 entitled "Packaging and Labeling Trends for 2010." This will help you understand what packaging designs are most suitable for your products and some things to consider when designing your product labels.
GetPersonalized! Pharma's perspective on the future, Claudia KarnbachSitra / Hyvinvointi
Pharma's perspective on the future, Claudia Karnbach, Head, Global Business Development and Licensing, Specialty Medicine, Bayer Healthcare Pharmaceuticals (USA, New York)
The history of Clamoxyl and how Amoxicillin came in to picture. Amoxycillin, is an antibiotic useful for the treatment of a number of bacterial infections. It is the first line treatment, presented by me and my teammates
Introduction to one of best medicine company Glaxo-smith-kline commonly known as GSK. this presentation gives detail introduction about GSK functions and products. Also global strategies which company is using.
Sharing my learning in dealing with complexity and uncertainty and shed some light on:
(a) Understanding the ‘biosimilar paradox’
(b) Accelerating our “QbD” Journey – focusing on ‘from Generics to Biosimilars’
(c) In preparing this talk, collect my thoughts to help NIPTE consider ways for developing its program on Biosimilars to help the Nation improve assurance of quality with confidence and lower costs
(D) Invite the audience to get to know NIPTE and provide us ways to collaborate with industry
The New Pharma Ecosystem: 2014 Trends Reshaping the Pharmaceutical Supply ChainLaura Olson
The pharmaceutical industry is undergoing tremendous changes. Numerous forces are re-shaping the new pharmaceutical ecosystem. Technology, demographics, regulations and shifts in wealth are creating transformative change. Increasingly becoming a more patient-centric world, patients use Smart devices to monitor research and evaluate pharmaceutical products. Healthcare reform regulations, the devaluation of the existing pharma model and trend towards patient empowerment and access to information are shaping the changing pharma industry, much as the retail industry was shaped by the multichannel and omni channel retailing trends of recent years. Regulators have become increasingly more cautious when improving innovative medicines. As pharmaceuticals have become more successful in prolonging life and treating illness, many medical conditions are now chronic. Today healthcare providers have become increasingly interested in measuring the outcomes of pharma performance and basing pricing accordingly. There has been a dramatic increase in prescription volume and an increased production and use of generic drugs. Producing pharmaceuticals in other countries can be complicated. Customs, local regulations and other factors impact products and require brands to adapt. Generic pharmaceuticals are becoming the dominant category globally, especially in developing rather than just industrial countries. Adding to the complexity, a large number of pharmaceutical products are made by multiple countries. These factors and the move towards specialty pharmaceuticals and greater production of pharmaceutical products globally have resulted in more pressure on global supply chains. Because supply chains have moved from local to global in operation, even one significant event can interrupt the global supply chain. Events such as hurricanes and typhoons, earthquakes, political and economic upheaval can have serious impacts on global supply chains, adding unforeseen costs and delays. Health care reform magnifies the effect of longer supply chains and increases the intense cost pressure on drug manufacturers. In order to reduce costs, more production as well as research and development are being offshored and outsourced.
STARBRANDS // BUILT TO SHINE: Krótka analiza rynku nutrikosmetyków / nutricos...SOFAMI.PL
Krótka analiza rynku nutrikosmetyków i obecnych tam marek i komunikacji marek. Our quick view on the nutricosmetics market, key players, brands, brand communication..
The history of Clamoxyl and how Amoxicillin came in to picture. Amoxycillin, is an antibiotic useful for the treatment of a number of bacterial infections. It is the first line treatment, presented by me and my teammates
Introduction to one of best medicine company Glaxo-smith-kline commonly known as GSK. this presentation gives detail introduction about GSK functions and products. Also global strategies which company is using.
Sharing my learning in dealing with complexity and uncertainty and shed some light on:
(a) Understanding the ‘biosimilar paradox’
(b) Accelerating our “QbD” Journey – focusing on ‘from Generics to Biosimilars’
(c) In preparing this talk, collect my thoughts to help NIPTE consider ways for developing its program on Biosimilars to help the Nation improve assurance of quality with confidence and lower costs
(D) Invite the audience to get to know NIPTE and provide us ways to collaborate with industry
The New Pharma Ecosystem: 2014 Trends Reshaping the Pharmaceutical Supply ChainLaura Olson
The pharmaceutical industry is undergoing tremendous changes. Numerous forces are re-shaping the new pharmaceutical ecosystem. Technology, demographics, regulations and shifts in wealth are creating transformative change. Increasingly becoming a more patient-centric world, patients use Smart devices to monitor research and evaluate pharmaceutical products. Healthcare reform regulations, the devaluation of the existing pharma model and trend towards patient empowerment and access to information are shaping the changing pharma industry, much as the retail industry was shaped by the multichannel and omni channel retailing trends of recent years. Regulators have become increasingly more cautious when improving innovative medicines. As pharmaceuticals have become more successful in prolonging life and treating illness, many medical conditions are now chronic. Today healthcare providers have become increasingly interested in measuring the outcomes of pharma performance and basing pricing accordingly. There has been a dramatic increase in prescription volume and an increased production and use of generic drugs. Producing pharmaceuticals in other countries can be complicated. Customs, local regulations and other factors impact products and require brands to adapt. Generic pharmaceuticals are becoming the dominant category globally, especially in developing rather than just industrial countries. Adding to the complexity, a large number of pharmaceutical products are made by multiple countries. These factors and the move towards specialty pharmaceuticals and greater production of pharmaceutical products globally have resulted in more pressure on global supply chains. Because supply chains have moved from local to global in operation, even one significant event can interrupt the global supply chain. Events such as hurricanes and typhoons, earthquakes, political and economic upheaval can have serious impacts on global supply chains, adding unforeseen costs and delays. Health care reform magnifies the effect of longer supply chains and increases the intense cost pressure on drug manufacturers. In order to reduce costs, more production as well as research and development are being offshored and outsourced.
STARBRANDS // BUILT TO SHINE: Krótka analiza rynku nutrikosmetyków / nutricos...SOFAMI.PL
Krótka analiza rynku nutrikosmetyków i obecnych tam marek i komunikacji marek. Our quick view on the nutricosmetics market, key players, brands, brand communication..
Team Bilcare practicing Yoga during World Yoga DayBilcareltd
Team Bilcare practicing Yoga during World Yoga Day
Organization has dedicated state-of-the-art meditation center
Yoga and Meditation is way of life in Bilcare to keep everyone happy!
Bilcare GCS, a leading clinical trial materials supplies and comparator drug sourcing player in Asia was recognized and ranked by White Page as part of this survey.
How can you build up long-lasting relationships with dialogue partners and use social media to attract and engage quality customers? By Jaydip Chowdhury
Rangoli Competition
Diya Decoration
Mouth watering lunch at Sky..
Musical ChairRamp walk
Fun filled Indoor Games
Sangeet Rajani
1 min act Award Distribution
Birthday Celebration
Mr. Mohan Bhandari, Chairman Bilcare speaks at prestigious 4th specialty films and flexible packaging global conference on role of barrier packaging and anti-counterfeit solutions for the pharmaceuticals
The program started with Bilcare’s pray and lightning of “Deep". Total 58 nominations received for the said award and they were felicitated by giving trophy & certificate with the auspicious hands of Mrs & Mr. Mohan Bhandari, Mr. Prakash Bhandari, Mr. Kiran Bhandari & Mr. Somenath Mukherjee during this program.
Our solution is based on over five years of intensive research and development. Our research has allowed us to deploy technology to uniquely identify items of value.
The Property Sector boom in India and the resulting exponential growth in registration volumes have also led to an increase in property related fraud and fake/illegal transactions.
How many patients does case series should have In comparison to case reports.pdfpubrica101
Pubrica’s team of researchers and writers create scientific and medical research articles, which may be important resources for authors and practitioners. Pubrica medical writers assist you in creating and revising the introduction by alerting the reader to gaps in the chosen study subject. Our professionals understand the order in which the hypothesis topic is followed by the broad subject, the issue, and the backdrop.
https://pubrica.com/academy/case-study-or-series/how-many-patients-does-case-series-should-have-in-comparison-to-case-reports/
ICH Guidelines for Pharmacovigilance.pdfNEHA GUPTA
The "ICH Guidelines for Pharmacovigilance" PDF provides a comprehensive overview of the International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH) guidelines related to pharmacovigilance. These guidelines aim to ensure that drugs are safe and effective for patients by monitoring and assessing adverse effects, ensuring proper reporting systems, and improving risk management practices. The document is essential for professionals in the pharmaceutical industry, regulatory authorities, and healthcare providers, offering detailed procedures and standards for pharmacovigilance activities to enhance drug safety and protect public health.
CHAPTER 1 SEMESTER V - ROLE OF PEADIATRIC NURSE.pdfSachin Sharma
Pediatric nurses play a vital role in the health and well-being of children. Their responsibilities are wide-ranging, and their objectives can be categorized into several key areas:
1. Direct Patient Care:
Objective: Provide comprehensive and compassionate care to infants, children, and adolescents in various healthcare settings (hospitals, clinics, etc.).
This includes tasks like:
Monitoring vital signs and physical condition.
Administering medications and treatments.
Performing procedures as directed by doctors.
Assisting with daily living activities (bathing, feeding).
Providing emotional support and pain management.
2. Health Promotion and Education:
Objective: Promote healthy behaviors and educate children, families, and communities about preventive healthcare.
This includes tasks like:
Administering vaccinations.
Providing education on nutrition, hygiene, and development.
Offering breastfeeding and childbirth support.
Counseling families on safety and injury prevention.
3. Collaboration and Advocacy:
Objective: Collaborate effectively with doctors, social workers, therapists, and other healthcare professionals to ensure coordinated care for children.
Objective: Advocate for the rights and best interests of their patients, especially when children cannot speak for themselves.
This includes tasks like:
Communicating effectively with healthcare teams.
Identifying and addressing potential risks to child welfare.
Educating families about their child's condition and treatment options.
4. Professional Development and Research:
Objective: Stay up-to-date on the latest advancements in pediatric healthcare through continuing education and research.
Objective: Contribute to improving the quality of care for children by participating in research initiatives.
This includes tasks like:
Attending workshops and conferences on pediatric nursing.
Participating in clinical trials related to child health.
Implementing evidence-based practices into their daily routines.
By fulfilling these objectives, pediatric nurses play a crucial role in ensuring the optimal health and well-being of children throughout all stages of their development.
Medical Technology Tackles New Health Care Demand - Research Report - March 2...pchutichetpong
M Capital Group (“MCG”) predicts that with, against, despite, and even without the global pandemic, the medical technology (MedTech) industry shows signs of continuous healthy growth, driven by smaller, faster, and cheaper devices, growing demand for home-based applications, technological innovation, strategic acquisitions, investments, and SPAC listings. MCG predicts that this should reflects itself in annual growth of over 6%, well beyond 2028.
According to Chris Mouchabhani, Managing Partner at M Capital Group, “Despite all economic scenarios that one may consider, beyond overall economic shocks, medical technology should remain one of the most promising and robust sectors over the short to medium term and well beyond 2028.”
There is a movement towards home-based care for the elderly, next generation scanning and MRI devices, wearable technology, artificial intelligence incorporation, and online connectivity. Experts also see a focus on predictive, preventive, personalized, participatory, and precision medicine, with rising levels of integration of home care and technological innovation.
The average cost of treatment has been rising across the board, creating additional financial burdens to governments, healthcare providers and insurance companies. According to MCG, cost-per-inpatient-stay in the United States alone rose on average annually by over 13% between 2014 to 2021, leading MedTech to focus research efforts on optimized medical equipment at lower price points, whilst emphasizing portability and ease of use. Namely, 46% of the 1,008 medical technology companies in the 2021 MedTech Innovator (“MTI”) database are focusing on prevention, wellness, detection, or diagnosis, signaling a clear push for preventive care to also tackle costs.
In addition, there has also been a lasting impact on consumer and medical demand for home care, supported by the pandemic. Lockdowns, closure of care facilities, and healthcare systems subjected to capacity pressure, accelerated demand away from traditional inpatient care. Now, outpatient care solutions are driving industry production, with nearly 70% of recent diagnostics start-up companies producing products in areas such as ambulatory clinics, at-home care, and self-administered diagnostics.
Deep Leg Vein Thrombosis (DVT): Meaning, Causes, Symptoms, Treatment, and Mor...The Lifesciences Magazine
Deep Leg Vein Thrombosis occurs when a blood clot forms in one or more of the deep veins in the legs. These clots can impede blood flow, leading to severe complications.
Health Education on prevention of hypertensionRadhika kulvi
Hypertension is a chronic condition of concern due to its role in the causation of coronary heart diseases. Hypertension is a worldwide epidemic and important risk factor for coronary artery disease, stroke and renal diseases. Blood pressure is the force exerted by the blood against the walls of the blood vessels and is sufficient to maintain tissue perfusion during activity and rest. Hypertension is sustained elevation of BP. In adults, HTN exists when systolic blood pressure is equal to or greater than 140mmHg or diastolic BP is equal to or greater than 90mmHg. The
India Clinical Trials Market: Industry Size and Growth Trends [2030] Analyzed...Kumar Satyam
According to TechSci Research report, "India Clinical Trials Market- By Region, Competition, Forecast & Opportunities, 2030F," the India Clinical Trials Market was valued at USD 2.05 billion in 2024 and is projected to grow at a compound annual growth rate (CAGR) of 8.64% through 2030. The market is driven by a variety of factors, making India an attractive destination for pharmaceutical companies and researchers. India's vast and diverse patient population, cost-effective operational environment, and a large pool of skilled medical professionals contribute significantly to the market's growth. Additionally, increasing government support in streamlining regulations and the growing prevalence of lifestyle diseases further propel the clinical trials market.
Growing Prevalence of Lifestyle Diseases
The rising incidence of lifestyle diseases such as diabetes, cardiovascular diseases, and cancer is a major trend driving the clinical trials market in India. These conditions necessitate the development and testing of new treatment methods, creating a robust demand for clinical trials. The increasing burden of these diseases highlights the need for innovative therapies and underscores the importance of India as a key player in global clinical research.
R3 Stem Cells and Kidney Repair A New Horizon in Nephrology.pptxR3 Stem Cell
R3 Stem Cells and Kidney Repair: A New Horizon in Nephrology" explores groundbreaking advancements in the use of R3 stem cells for kidney disease treatment. This insightful piece delves into the potential of these cells to regenerate damaged kidney tissue, offering new hope for patients and reshaping the future of nephrology.
R3 Stem Cells and Kidney Repair A New Horizon in Nephrology.pptx
Bilcare brandpak
1.
2. In an industry where
Tangible Product Differentiation
is not always possible
Can packaging create that competitive advantage?
Packaging ….
The 5th P of marketing is relatively
under utilised in pharma for creating
product differentiation
4. We resolve brand challenges
through innovative packaging solutions
to improve brand revenue
• Brand differentiation
• Rx to OTC shift
• Premium image
• Innovator/Global identity
• Corporate branding etc.
‘s
Counterfeit
Compliance
Convenience
Communication
Child Resistant
5. The European Outsourcing
Awards 2008
Innovative Blister Packaging Solution
for Brand Challenges
Bilcare Research
Best New Product
6. Epidemic of Medication Non-Compliance
• In the US, out of 3.8 billion out prescriptions,
50% of them are taken incorrectly or not at all
• A study of over 75,000 patients found that for
chronic conditions such as high blood pressure, diabetes,
and high cholesterol Rx not filled 20%-22% of the time.
• Poor compliance accounts for 33%-69% of drug-related
adverse events resulting in hospitalisation
• Even among chronically ill patients who regularly fill their prescriptions,
only about half the doses taken are taken as their physicians intend.
• Poor compliance with medication regimens is associated up to 40% of nursing home admissions.
One upshot: Poor medication compliance is implicated in over 125,000 US deaths per year.
7. Incidence of Accidental Misuse
of medicines in Children
In 2012, 64,000 kids were treated in
emergency rooms for medicine poisoning.
That’s one child every eight minutes,
according to a new report from Safe Kids
The US Poison Control Centre
receives nearly 500,000 calls per year
related to young children accidentally getting into medicine;
3 of 4 cases of child drug poisonings, the medication belonged to parent
(39 percent of cases) or grandparent (38 percent of cases)
Deaths from prescription drug overdoses have been called the "silent epidemic" for years, and
with 1 American dying every 19 minutes from an accidental prescription drug overdose,
it's being described as "the biggest man-made epidemic in the US."
8. Innovative Packaging Solution
for Compliance
• Kit packs have following concerns:
- There were different drugs each having different dosage regimen
- To ensure dosage compliance was a major challenge
• Oral contraceptive had following concerns:
- Packs being small and dosage indicators not visible
- While opening, adjacent tablet was popping out
- Tablets being small… often fall down
12. Innovative Packaging Solution
for Preventing Counterfeit
• Brand growth was stagnating
affected by counterfeit and pass-off
• Other calcium therapy brands from generic
division of pharmacos were riding on pack
equity of Shelcal and brand was substituted
• Sales doubled in three years after
introducing Bilcare’s anti-counterfeit
packaging film
• Counterfeit and pass-off got arrested …
marketing strategy activated
13. Innovative Packaging Solution
for Communication
Blister inside Pouch ….
Zip-lock Pouch replaced carton
to carry blister as it was more
convenient and also ensured
involvement of chemists
Patient Communication ….
Rear side of pouch carries
useful information for patient
- Medication to be taken
morning,afternoon
and/or evening
- Medication to be taken
before or after meals
- Medication to be taken
for how many days
- Pharmacist can tick
concerned boxes
14. Innovative Packaging Solution
for Convenience
• When most cough preparations were in bottles with
minimal differential… how to create differentiation
• Bottle is not convenient to carry and use esp.
by working class patients
• Everyone may not need full bottle to resolve cough
• Single serve’s provided convenience, increased affordability,
decreased wastage and increased brand recall
15. Innovative Packaging Solution
for building Indication-Brand association
• Brand was late entrant in
iron preparation segment market
• There was no tangible product differentiation
• Package design developed in-line with
‘user condition’ to build strong
association to ensure patient stay’s-on therapy
16. Innovative Packaging Solution
for Corporate Branding
• Company wanted to differentiate itself
through premium packaging
• Cold form foil had become increasingly
popular and lacked distinction
• Bilcare Venus offering printing on cold form
provided the distinction and corporate identity
17. Innovative Packaging Solution
for OTX Communication
• Brand was leader in anti-nauseant therapy segment
• Challenge was to increase sales by
exploiting the OTX potential
• A subtle change in packaging thro unique branding
and unique colour identity ensured high recall
• New pack ensured OTX usage without
compromising Rx identity
18. Innovative Packaging Solution
for Unique Brand Identity
• For power brands it is important to
have unique brand identity
• Power brands adopted strategy
to differentiate through packaging
providing unique brand identity
19. Innovative Packaging Solution
to Prevent Substitution
• In branded generics category it has
become increasingly important to have
tangible differentiation
• Leading brands adopted strategy
to differentiate through innovative
packaging to prevent substitution
20. Bilcare - Innovative Single Tablet Dispenser
• Blister pack in form of a coil
is housed in a plastic container
• Pivoted switch is provided
which is spring loaded
• The switch has to be pressed to
dispense a unit distance of the
coiled blister pack/strip
• The blister strip has V notch at unit distances
and can be torn off once it is dispensed from window
• The switch springs back to original position when
pressure is released and the whole arrangement is
ready for a new cycle